Table of Content

1. Introduction to Galectin Inhibitors
1.1 Overview
1.2 Discovery of Galectins & Their Inhibitors


2. Role of Galectin Inhibitors & Mechanism of Action by Indication
2.1 Cancer
2.2 Viral Infection
2.3 Liver Diseases
2.4 Neurodegenerative Disease
2.5 Cardiovascular Diseases


3. Global Galectin Inhibitors Clinical Trials Landscape
3.1 By Company
3.2 By Country
3.3 By Indication
3.4 By Phase
3.5 By Patient Segment


4. Global Galectin Inhibitors Clinical Pipeline By Company, Indication & Phase
4.1 Research
4.2 Preclinical
4.3 Phase-I/II
4.4 Phase-II
4.5 Phase-II/III


5. Global Galectin Inhibitors Market Dynamics
5.1 Favorable Factors & Opportunities
5.2 Challenges & Restraints


6. Global Galectin Inhibitors Market Opportunity Outlook


7. Competitive Landscape
7.1 BioXyTran
7.2 G3 Pharmaceuticals
7.3 Galectin Therapeutics
7.4 Galecto
7.5 GlycoMimetics
7.6 HiFiBiO
7.7 PureTech Health
7.8 TrueBinding
7.9 University Medical Center Groningen
7.10 University Of Michigan Medical School



List of Figures

Figure 1-1: Timeline of Discovery of Galectin Inhibitors

Figure 2-1: Roles of Galectins in Cancer
Figure 2-2: LYT-200 Phase I/II Study – Initiation & Completion Years
Figure 2-3: GR-MD-02 Phase I Study – Initiation & Completion Years
Figure 2-4: GB1211 Phase I/II Study – Initiation & Completion Years
Figure 2-5: Roles of Galectins in Viral Infections
Figure 2-6: ProLectin M Phase III PROTECT Study – Initiation & Completion Years
Figure 2-7: ProLectin-M Phase II Study – Initiation & Completion Years
Figure 2-8: Roles of Galectins in Liver Diseases
Figure 2-9: Belapectin Phase II/III NAVIGATE Study – Initiation & Completion Years
Figure 2-10: GB1211 Phase I/II GULLIVER-2 Study – Initiation & Completion Years
Figure 2-11: Roles of Galectins in Neurodegenerative Disease
Figure 2-12: Roles of Galectins in Cardiovascular Diseases

Figure 3-1: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Company (Numbers), 2023
Figure 3-2: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Country (Numbers), 2023
Figure 3-3: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Indication (Numbers), 2023
Figure 3-4: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Phase (Numbers), 2023
Figure 3-5: Global - Galectin Inhibitors Drugs In Clinical Pipeline By Patient Segment (Numbers), 2023

Figure 5-1: Factors Driving Galectin Inhibitors Market
Figure 5-2: Factors Limiting Galectin Inhibitors Market

List of Tables

Table 2-1: Galectins & Their Disease Implications